A metabolic vulnerability of pancreatic ductal adenocarcinoma (PDAC) could be used to address this type of cancer that often resists treatments. Scientists at the University of Michigan have ...

While sprinkling cinnamon on food is likely safe, concentrated supplements might pose risks, especially for people taking ...

In further support of that finding, the researchers determined—with the help of AI—that PHGDH plays a previously undiscovered ...

Lorundrostat, a selective aldosterone synthase inhibitor, significantly reduced systolic blood pressure in patients with ...

The study found people who used proton pump inhibitors for more than 4.4 years were 33% more likely to be diagnosed with the ...

Neurologists have discovered that a common household drug, which has been previously linked to higher risk of stroke, broken ...

Regularly taking this tablet could increase the risk of developing the degenerative disease by as much as a third.

Researchers have developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially ...

Pancreatic cancer is a leading cause of cancer-related death, with a five-year survival rate of 13%. The high mortality is ...

NS-229 is an investigational selective Janus kinase 1 inhibitor designed to prevent tissue damage caused by EGPA by suppressing immune cell activation.

Expands Development Portfolio with Introduction of a Novel Program Targeting PSC – – Confirms Highly Specific Allosteric ACLY Inhibitor Shown to Reduce Liver Injury, Inflammation and Fibrosis Across ...

After adjusting for factors such as age, sex and race, as well as health-related issues such as high blood pressure and ...